Search
Close this search box.

GAfPA Statement on United States-Mexico-Canada Agreement

Patients who are eager for the next generation of treatments and cures will be well served by the United States-Mexico-Canada Agreement.  This agreement provides intellectual property protections that promote patient access to innovative medicine, clearing the way for new treatments for cancer, Alzheimer’s, diabetes and many other conditions.